Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1492519 Title: METHODES DE TRAITEMENT DE TROUBLES DES VOIES URINAIRES INFERIEURES UTILISANT DES DES AGENTS ANTIMUSCARINIQUES ET DES MODULATEURS DES CANAUX CALCIQUES DE LA SOUS-UNITE ALPHA-2-DELTA

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
047579495
WO application number:
US2004008605
Type:
European patent granted for BE
Status:
Publication number:
1492519
WO publication number:
WO 2004/084879
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:

Dates

Filing date:
22/03/2004
Grant date:
15/11/2006
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
02/02/2007
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
EP B1 publication date:
15/11/2006
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/03/2009
Expiration date (if granted and all annual fees paid):

Applicant

Name:
Dynogen Pharmaceuticals, Inc.
Legal Form:
From:
15/11/2006
Address:
52 Second Avenue Waltham MA 02451(US), US
To:

Priority

1

Priority patent number:
456835 P
Priority date:
21/03/2003
Priority country:
United States (US)

2

Priority patent number:
486148 P
Priority date:
10/07/2003
Priority country:
United States (US)

3

Priority patent number:
509570 P
Priority date:
08/10/2003
Priority country:
United States (US)

4

Priority patent number:
534871 P
Priority date:
08/01/2004
Priority country:
United States (US)

5

Priority patent number:
548250 P
Priority date:
27/02/2004
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/195 ; A61K 31/216 ; A61K 31/197 ; A61K 31/137 ; A61K 31/445 ; A61K 31/4725 ; A61P 13/00;

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
30/04/2008
Last annual fee paid number:
Payer:

Additional information section

Status:
Case kind / Max duration / Publication code:
Basic patent details (Patent law 1854):
Representative details:
PLUCKER Guy-OFFICE KIRKPATRICK S.A.-Avenue Wolfers 32 - B 1310 LA HULPE
Inventor(s) details:
FRASER, Matthew, Oliver;THOR, Karl, Bruce;BURGARD, Edward, C.;BRETTMAN, Lee, R.;LANDAU, Steven, B.;RICCA, Daniel, J.;
History of owners:
Filing date Document type Publication Type Document Description Number of pages File Type
02/02/2007 General Document (TP - T:Traduction Originale plus Pouvoir) 227 PDF /9/1/5/2/9/0611492519/migrated-docs/047579495_1_211463.pdf